S-adenosylhomocysteine hydrolase (AdoHcyHD) is an ubiquitous enzyme that catalyzes the breakdown of S-adenosylhomocysteine, a powerful inhibitor of most transmethylation reactions, to adenosine and L-homocysteine. AdoHcyHD from the hyperthermophilic archaeon Pyrococcus furiosus (PfAdoHcyHD) was cloned, expressed in Escherichia coli, and purified. The enzyme is thermoactive with an optimum temperature of 95 degrees C, and thermostable retaining 100% residual activity after 1 h at 90 degrees C and showing an apparent melting temperature of 98 degrees C. The enzyme is a homotetramer of 190 kDa and contains four cysteine residues per subunit. Thiol groups are not involved in the catalytic process whereas disulfide bond(s) could be present since incubation with 0.8 M dithiothreitol reduces enzyme activity. Multiple sequence alignment of hyperthermophilic AdoHcyHD reveals the presence of two cysteine residues in the N-terminus of the enzyme conserved only in members of Pyrococcus species, and shows that hyperthermophilic AdoHcyHD lack eight C-terminal residues, thought to be important for structural and functional properties of the eukaryotic enzyme. The homology-modeled structure of PfAdoHcyHD shows that Trp220, Tyr181, Tyr184, and Leu185 of each subunit and Ile244 from a different subunit form a network of hydrophobic and aromatic interactions in the central channel formed at the subunits interface. These contacts partially replace the interactions of the C-terminal tail of the eukaryotic enzyme required for tetramer stability. Moreover, Cys221 and Lys245 substitute for Thr430 and Lys426, respectively, of the human enzyme in NAD-binding. Interestingly, all these residues are fairly well conserved in hyperthermophilic AdoHcyHDs but not in mesophilic ones, thus suggesting a common adaptation mechanism at high temperatures.

Download full-text PDF

Source
http://dx.doi.org/10.1002/prot.20381DOI Listing

Publication Analysis

Top Keywords

s-adenosylhomocysteine hydrolase
8
archaeon pyrococcus
8
pyrococcus furiosus
8
enzyme
8
temperature degrees
8
cysteine residues
8
hyperthermophilic adohcyhd
8
eukaryotic enzyme
8
hydrolase archaeon
4
furiosus biochemical
4

Similar Publications

Dysmorphic Findings in SAHH Deficiency with a Novel Variant in the Gene.

Mol Syndromol

December 2024

Department of Medical Genetics, University of Health Sciences, Van Training and Research Hospital, Van, Turkey.

Introduction: S-adenosylhomocysteine hydrolase (SAHH) is one of the enzymes involved in converting methionine to homocysteine with transmethylation processes. Methyltransfer reactions are impaired in SAHH deficiency. SAHH deficiency is multisystemic and antenatal onset disorder.

View Article and Find Full Text PDF

S-adenosylmethionine and S-adenosyl-L-homocysteine metabolism is involved in the sperm motility and in vitro fertility rate in mouse.

Biochem Biophys Res Commun

December 2024

Department of Cellular Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Neutron Therapy Research Center, Okayama University, Okayama, Japan. Electronic address:

Increased fragmentation of sperm DNA has been implicated in male infertility. Folate deficiency results in impaired methionine synthesis, depletion of S-adenosylmethionine (SAM) levels, an increase in S-adenosyl-l-homocysteine (SAH) levels, and increased DNA fragmentation. Disruption of the dynamic balance between SAM and SAH may also contribute, although the details of this process are not yet fully understood.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis is a widespread chronic skin condition, and the role of S-adenosine homocysteine hydrolase (AHCY) in its development and its effects on DNA methylation had not been thoroughly examined.
  • This study explored how AHCY expression in psoriatic lesions relates to disease severity and its effects on keratinocyte behavior and DNA methylation through knockdown experiments.
  • The results show that AHCY is elevated in psoriasis, contributes to disease severity, and alters DNA methylation patterns, suggesting that targeting AHCY could be a potential therapeutic approach for treating psoriasis.
View Article and Find Full Text PDF
Article Synopsis
  • S-adenosylhomocysteine hydrolase deficiency is an autosomal recessive metabolic disorder disrupting the methionine cycle, which can range from severe symptoms to asymptomatic cases.
  • Two clinically asymptomatic siblings from Pakistan were diagnosed with mild chronic liver failure and other mild symptoms, with one sibling showing improvements after dietary changes.
  • The research highlights a specific genetic variant common in South Asia and suggests this milder form of the disease may be underdiagnosed, emphasizing the need for better therapeutic management to prevent future health complications.
View Article and Find Full Text PDF

In memory of an exquisite medicinal chemist, Prof. Morris Robins.

Nucleosides Nucleotides Nucleic Acids

November 2024

Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, B-3000Leuven, Belgium.

Among the most prominent realizations of Morris J. Robins in the antiviral nucleoside chemistry are the synthesis of 8-substituted (methyl-, amino-, bromo-, iodo) derivatives of acyclovir, xylotubercidin as an inhibitor of herpes simplex virus (HSV) infections, the anti-HIV activity of the 2',3'-dideoxyriboside of 2,6-diaminopurine (ddDAPR) and the 3'-azido- and 3'-fluoro derivatives thereof (AzddDAPR and FddDAPR, respectively), the potentiating effect of ribavirin on the anti-HIV activity of 2',3'-dideoxyinosine (ddI) and ddDAPR, S-adenosylhomocysteine hydrolase (SAH) inhibitors principally active against vaccinia virus (VV) and vesicular stomatitis virus (VSV), and furo[2,3-d]pyrimidinone derivatives active against varicella-zoster virus (VZV).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!